PTGX
Protagonist Therapeutics, Inc.NASDAQStock$151.29+0.60 (+0.40%)Mkt Cap 9.7BP/E —Div Yield —Beta 1.79Vol 226.3KAvg Vol 504.0K
52W$56.19
$158.62
ETFs That Hold PTGX (Protagonist Therapeutics, Inc.)
1M
+11.60%
3M
+50.67%
6M
+64.30%
YTD
+73.54%
1Y
+165.47%
3Y
+647.11%
5Y
+216.04%
ETFs That Hold PTGX
Protagonist Therapeutics, Inc. is held by 128 ETFs. The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.02% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.01% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.01% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.01% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.01% |
| IRTR | iShares LifePath Retirement ETF | 0.00% |
Excludes leveraged and inverse ETFs.
PreviousPage 7 of 7
Frequently Asked Questions
How many ETFs hold PTGX?
Protagonist Therapeutics, Inc. (PTGX) is held by 128 ETFs (excluding leveraged and inverse funds). The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).
What is the largest ETF that holds PTGX?
By fund size, IJR (iShares Core S&P Small-Cap ETF) with $111.19B in AUM holds 0.52% of its portfolio in PTGX, representing $583.7M in market value.
What percentage of NBDS is PTGX?
PTGX makes up 4.61% of NBDS (Neuberger Berman Disrupters ETF), making it one of the largest positions in that fund.
Is PTGX in the S&P 500?
PTGX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.